About Arbor Biotechnologies
Arbor Biotechnologies is a company based in Cambridge (United States) founded in 2016 by David Scott and Winston Yan.. Arbor Biotechnologies has raised $304.1 million across 4 funding rounds from investors including Vertex Pharmaceuticals, T. Rowe Price and Temasek. The company has 117 employees as of December 31, 2022. Arbor Biotechnologies has completed 1 acquisition, including Serendipity Biosciences. Arbor Biotechnologies offers products and services including Gene Editing Toolbox and Pipeline Products. Arbor Biotechnologies operates in a competitive market with competitors including Singleron, Octant, Diagenode, Factor Bioscience and Novomics, among others.
- Headquarter Cambridge, United States
- Employees 117 as on 31 Dec, 2022
- Founders David Scott, Winston Yan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arbor Biotechnologies, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$304.1 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Vertex Pharmaceuticals
& 26 more
-
Employee Count
117
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arbor Biotechnologies
Arbor Biotechnologies offers a comprehensive portfolio of products and services, including Gene Editing Toolbox and Pipeline Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides tools for developing next-generation gene editing treatments.
Advances gene editing for various genetic disease applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Arbor Biotechnologies
Arbor Biotechnologies has successfully raised a total of $304.1M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(02 Aug 2017)
- Investors Count 27
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series C - Arbor Biotechnologies | Valuation |
investors |
|
| Mar, 2025 | Amount | Series C - Arbor Biotechnologies | Valuation | Arch Venture Partners , TCG Crossover | |
| Nov, 2021 | Amount | Series B - Arbor Biotechnologies | Valuation | Temasek , TCG Crossover |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arbor Biotechnologies
Arbor Biotechnologies has secured backing from 27 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Vertex Pharmaceuticals, T. Rowe Price and Temasek. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
PE firm investing in South Korea and the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arbor Biotechnologies
Arbor Biotechnologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Serendipity Biosciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene-editing technology and genetic medicines are developed for therapeutic uses.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Arbor Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arbor Biotechnologies Comparisons
Competitors of Arbor Biotechnologies
Arbor Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Singleron, Octant, Diagenode, Factor Bioscience and Novomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| domain | founded_year | HQ Location |
Human cell interaction platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Reagents and kits for epigenetics sequencing solutions are developed.
|
|
| domain | founded_year | HQ Location |
Genomic technologies are developed to treat diseases and enhance health.
|
|
| domain | founded_year | HQ Location |
Molecular diagnosis systems for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arbor Biotechnologies
Frequently Asked Questions about Arbor Biotechnologies
When was Arbor Biotechnologies founded?
Arbor Biotechnologies was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Arbor Biotechnologies located?
Arbor Biotechnologies is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Arbor Biotechnologies a funded company?
Arbor Biotechnologies is a funded company, having raised a total of $304.1M across 4 funding rounds to date. The company's 1st funding round was a Series B of $215M, raised on Aug 02, 2017.
How many employees does Arbor Biotechnologies have?
As of Dec 31, 2022, the latest employee count at Arbor Biotechnologies is 117.
What does Arbor Biotechnologies do?
Arbor Biotechnologies was founded in 2016 in Cambridge, United States, within the biotechnology sector. A platform is operated that integrates artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening to facilitate protein discovery. A new CRISPR enzyme has been identified through this platform. Operations focus on advancing genomic tools for research and therapeutic development in the life sciences field.
Who are the top competitors of Arbor Biotechnologies?
What products or services does Arbor Biotechnologies offer?
Arbor Biotechnologies offers Gene Editing Toolbox and Pipeline Products.
How many acquisitions has Arbor Biotechnologies made?
Arbor Biotechnologies has made 1 acquisition, including Serendipity Biosciences.
Who are Arbor Biotechnologies's investors?
Arbor Biotechnologies has 27 investors. Key investors include Vertex Pharmaceuticals, T. Rowe Price, Temasek, Janus Henderson Investors, and Piper Sandler.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.